Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving capecitabine together with tipifarnib works
in treating women with taxane-resistant metastatic breast cancer. Drugs used in chemotherapy,
such as capecitabine, work in different ways to stop tumor cells from dividing so they stop
growing or die. Tipifarnib may stop the growth of tumor cells by blocking the enzymes
necessary for their growth. Giving capecitabine together with tipifarnib may kill more tumor
cells